Viscoelasticity and Interface Properties of Multi-Component Condensates Govern Protein Sequestration and Suppression of Amyloid Formation
Contrary to the prevailing view that stress granules act as crucibles for amyloid formation, this study demonstrates that multi-component biomolecular condensates robustly suppress fibril formation by sequestering proteins, constraining growth through viscoelasticity, and mitigating nucleation at interfaces.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside every living cell, there is a constant struggle to keep proteins in their proper shape. Proteins are the workhorses of life, but when they lose their form, they can clump together into rigid, rope-like structures called amyloid fibrils. These clumps are the hallmark of devastating diseases like Alzheimer's and ALS, where they accumulate and damage nerve cells. For years, scientists have watched these clumps form near tiny, liquid-like droplets inside cells known as stress granules. Because these droplets are packed with the very proteins that tend to clump, many researchers believed the droplets acted as crucibles, cooking up the dangerous fibrils. The prevailing idea was that by crowding these proteins together, the droplets made it easier for them to snap into their rigid, harmful shapes.
A team of researchers at the University at Buffalo, St. Jude Children's Research Hospital, and other institutions has now turned this idea on its head. By building artificial versions of these cellular droplets in a lab and watching them closely, they discovered that the droplets actually do the opposite: they act as protective shields. Instead of helping the proteins turn into harmful ropes, the droplets soak them up and keep them safe, preventing the formation of the dangerous clumps that drive neurodegenerative disease.
To test this, the scientists created a model system using simple building blocks that mimic the complex environment of a stress granule. They mixed short strands of DNA with specific protein-like peptides to form liquid droplets, then added three different proteins known to form amyloid fibrils in human disease: hnRNPA1, Tau, and FUS. In a normal solution without these droplets, the proteins quickly began to clump together, forming fibrils within about an hour and a half. However, when the researchers added the droplets, the process slowed down dramatically. The more droplets they added, the longer it took for the fibrils to appear. In some cases, the formation of the harmful ropes was delayed by hours, or stopped almost entirely. The droplets were not helping the proteins clump; they were holding them back.
The researchers then used high-powered microscopes to see exactly where the fibrils were forming. They expected to find the ropes growing inside the liquid droplets, where the protein concentration was highest. Instead, they found the opposite. The fibrils were forming in the thin, watery space surrounding the droplets, not inside them. The droplets acted like a sponge, pulling the proteins out of the surrounding water and trapping them inside. This reduced the number of free-floating proteins available to start the clumping process. The droplets essentially hid the building blocks of the disease, making it much harder for the harmful ropes to get started.
However, the story is not entirely simple. The researchers found that the surface of these droplets, where the liquid meets the watery surroundings, can sometimes help the clumping start. If the droplets are not very thick or sticky, proteins can gather at the edge and begin to form the initial seeds of the fibrils. But even when these seeds formed at the surface, the actual growth of the long, damaging ropes happened in the water outside. The droplets themselves remained clear and liquid, while the damage occurred in the space around them.
A crucial factor in how well the droplets protected the proteins was their internal texture, or how "thick" and stretchy they were. The team created droplets with different levels of stiffness, ranging from very runny to extremely viscous, almost like thick honey. They discovered that the stiffer, more viscous droplets were far better at stopping the fibrils. When a protein tried to leave a stiff droplet to join a growing rope in the water, it moved much more slowly. The thick, stretchy network inside the droplet held the proteins back, creating a traffic jam that prevented them from reaching the fibrils. In contrast, proteins could escape from runny droplets much faster, allowing the clumping to proceed more quickly.
To confirm these findings applied to real biology, the scientists moved from their simple lab models to complex systems that more closely resemble actual human cells. They created stress granules using components found in human cells, including a key protein called G3BP1 and RNA. These biological droplets behaved exactly like their artificial counterparts: they soaked up the disease-causing proteins and slowed down the formation of fibrils. They even tested these effects in living human cells, where they found that making the stress granules stiffer further delayed the clumping process.
The study suggests that stress granules are not the villains they were once thought to be. Instead of being factories that manufacture the toxic clumps found in neurodegenerative diseases, they appear to be a defense mechanism evolved by cells to protect themselves. By sequestering vulnerable proteins and slowing their movement, these droplets buy the cell time to recover from stress. The danger arises only when this protective system fails, perhaps due to mutations that make the droplets too weak to hold the proteins, or when the proteins become so sticky that they overwhelm the system. This new understanding shifts the focus from trying to break up these droplets to finding ways to strengthen them, potentially offering a new path for treating diseases where protein clumping goes wrong.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.